|Articles|April 1, 2014
- Applied Clinical Trials-04-01-2014
- Volume 23
- Issue 4
Applied Clinical Trials Digital Edition April/May 2014
Sites: Making a Difference in Cancer Trials Accrual Trial Design: Oncology Trial Comparator Drug Reimbursement Also in this issue: Singular Approach to Combination Trials Risk Sharing and Interrupted Drug Development Cardio-Oncology: A New Clinical Discipline
Advertisement
Articles in this issue
over 12 years ago
Oncology Trial Comparator Drug Reimbursement: A Canadian Perspectiveover 12 years ago
Business and People April 2014over 12 years ago
Europe Puts Renewed Emphasis on Patient Communicationover 12 years ago
Making a Difference in Cancer Trials Accrualover 12 years ago
Analyzing 2013 Oncology Trends to Predict 2014 Directionsover 12 years ago
Singular Approaches to Combination Trialsover 12 years ago
Delivery Strength from Midsize CROsover 12 years ago
Pressure Grows for More Inclusive Clinical Trialsover 12 years ago
Coming to Terms with Interrupted Drug Development Programsover 12 years ago
The New Road of Cardio-Oncology in Clinical DevelopmentAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection
2
ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access
3
ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion
4
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
5